the form opens in a new tab
Late submission deadline: 30th June 2018
Abstract selection for oral or poster presentation
Abstracts submitted until the early submission deadline will be subject to peer review by at least 2 members of the Scientific Committee. The Scientific Committee is responsible for the final decisions regarding presentation format (poster or oral presentation). Abstracts submitted after the early submission deadline will be peer reviewed by 1 member of the Scientific Committee and 1 member of Organizing Committee but will only be considered for poster presentations.
The presenting authors will be notified of acceptance by email (please make sure to state your correct email address).
If you do not receive a confirmation by email within the established deadlines, please contact the BIO2018 secretariat.
Włodzimierz Mozołowski Award
The poster or oral presentation eligible (young scientists under 30 yrs) to Włodzimierz Mozołowski Award will be evaluated and nominated by the panel selected by the Polish Biochemical Society.
For the rules and conditions see Nagroda im. Włodzimierza Mozołowskiego
Janina Opieńska-Blauth Scholarship
The poster or oral presentation by student participant eligible to Janina Opieńska-Blauth Scholarship (for the rules see Stypendium im. J. Opieńskiej-Blauth) will be evaluated and nominated by the Polish Biochemical Society.
Candidates are asked to apply to Dr. Teresa Wesołowska: email@example.com
Wacław Szybalski Foundation Award
Wacław Szybalski Foundation Award for the best poster presentation will be granted among all Congress participants regardless of age.
Candidates to this award are asked to apply by e-mail to: firstname.lastname@example.org
Guidelines for oral presentation
Oral presentation selected by the Scientific Committee should be planned for 10 min talk that will be followed by 5 min discussion. Presentation time will be strictly enforced.
Guidelines for poster presentation
The posters have to be printed for display on a poster board (size to be announced later).
Posters should be on display throughout the Congress i.e.
Group of Poster Session 1: from 09.00 hours to 18.00 hours on Wednesday 19th September.
Poster Session 1: 13:15-14:30
Session Nos 1-10:
Group of Poster Session 2: from 09.00 hours to 18.00 hours on Thursday 20th September.
Poster Session 2: 13:15-14:15
Session Nos 11-20:
Group of Poster Session 3: from 09.00 hours to 15.00 hours on Friday 21st September.
Poster Session 3: 13:15-14:00
Session Nos 21-30 and the late abstracts
All posters will be numbered, listed and grouped in accordance with the Congress topics. Authors must be available to present and discuss their poster during the session.
The poster area opens for poster presenters on Wednesday 19th September at 08:00. Assistants will be available on site to provide you with the material needed to attach your poster to its stand. Please take notice of your Abstract number and poster board before hanging up your poster.
Posters should be constructed in the format which will be announced later. To enable delegates to easily read the information the lettering should be a minimum of 1 cm high.
Please select the session under which you wish to submit your abstract for review by the Scientific Committee.
The reviewers may decide that the abstract content, while otherwise acceptable, does not fit the interest area of the topic to which it was submitted. In this case, the abstract is forwarded to the Review Committee of the topic more closely aligned to the perceived content.
1. Genomics and genomics - driven research
2. RNA and RNP structures and mechanisms of action: from theory to experiment
3. EMBO Session
4. Signaling in plant cells
5. Evolutionary biochemistry
6. Non-coding RNA and gene expression
7. Structural studies of large assemblies
8. Molecular bioenergetics
9. The physiological and pharmacological regulation of endobiotic and drug metabolizing enzymes
10. Endothelial dysfunction and atherosclerosis
11. Medical biotechnology in regenerative medicine and drug research
12. Molecular virology and gene therapy
13. Metabolic activation of xenobiotics –therapeutic target and drug monitoring
14. New biomarkers in neurodegenerative diseases
15. New molecular targets in personalized therapy of cancer
16. Clinical metabolomics
17. Tumor microenvironment in cancer progression
18. New molecular targets in personalized therapy of autoimmune diseases
19. Inside plant organelles: structure, function and stress response
20. Plant biochemistry and metabolomics
21. CRISPR technologies for targeted genome editing
22. Proteomics of ageing and diseases
23. Entanglement in biology - from proteins folding to drug design
24. Mitochondrialand lysosomal diseases
25. NGS in biomedical sciences
26. From experimental data to in silico simulations and way back
27. Biochemistry of the connective tissue
28. Inflammation and cancer
29. Marine biotechnology
30. Modeling of radiation damage to DNA
31. COST Action CA16112 "NutRedOx" Session: Redox control of major age-related diseases
the form opens in a new tab